Literature DB >> 7682252

Identification of antigenic sites mediating antibody-dependent enhancement of feline infectious peritonitis virus infectivity.

C W Olsen1, W V Corapi, R H Jacobson, R A Simkins, L J Saif, F W Scott.   

Abstract

We have previously demonstrated antibody-dependent enhancement of feline infectious peritonitis virus (FIPV) infection of macrophages using both virus-specific antisera and monoclonal antibodies (MAbs) to the spike (S) protein of FIPV. To increase our understanding of this phenomenon, six representative MAbs from a previously documented group of 12 enhancing MAbs were used to identify epitopes that mediate antibody-dependent enhancement of FIPV infectivity. Analysis of the results of kinetics-based competitive ELISA (K-cELISA) among these six enhancing MAbs grouped the epitopes into two clusters. Because transmissible gastroenteritis virus (TGEV) and FIPV are so closely related antigenically, we also conducted K-cELISA experiments between the FIPV MAbs and TGEV S protein-specific MAbs for which the epitopes had previously been mapped to specific sites on the TGEV S protein. Results of these assays indicated that the two FIPV epitope clusters are homologues of the previously defined TGEV S protein sites A and E/F. In addition, two TGEV S protein-specific MAbs also induced antibody-dependent enhancement of FIPV infection of macrophages. This functional cross-reactivity provides further support for the close antigenic relationship between FIPV and TGEV. Our results provide a preliminary localization of several enhancing epitopes within the amino acid sequence of the FIPV S protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682252     DOI: 10.1099/0022-1317-74-4-745

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  26 in total

1.  Infectivity-neutralizing and hemagglutinin-inhibiting antibody responses to respiratory coronavirus infections of cattle in pathogenesis of shipping fever pneumonia.

Authors:  X Lin; K L O'Reilly; M L Burrell; J Storz
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

2.  B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein.

Authors:  Xiaofen Zhong; Huanghao Yang; Zu-Feng Guo; Wan-Yee Fion Sin; Wei Chen; Junjie Xu; Ling Fu; Jie Wu; Chun-Kit Gannon Mak; Chak-Sum Samuel Cheng; Yanzhen Yang; Shuyong Cao; Tin-Yau Wong; Sik-To Lai; Yong Xie; Zhihong Guo
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 3.  SARS vaccine development.

Authors:  Shibo Jiang; Yuxian He; Shuwen Liu
Journal:  Emerg Infect Dis       Date:  2005-07       Impact factor: 6.883

4.  Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus.

Authors:  Thomas C Greenough; Angela Carville; James Coderre; Mohan Somasundaran; John L Sullivan; Katherine Luzuriaga; Keith Mansfield
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

5.  Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry.

Authors:  Yuxian He; Yusen Zhou; Pamela Siddiqui; Shibo Jiang
Journal:  Biochem Biophys Res Commun       Date:  2004-12-10       Impact factor: 3.575

6.  Cellular composition and interferon-gamma expression of the local inflammatory response in feline infectious peritonitis (FIP).

Authors:  A-L Berg; K Ekman; S Belák; M Berg
Journal:  Vet Microbiol       Date:  2005-09-23       Impact factor: 3.293

7.  Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease.

Authors:  Luis Enjuanes; Marta L Dediego; Enrique Alvarez; Damon Deming; Tim Sheahan; Ralph Baric
Journal:  Virus Res       Date:  2007-04-09       Impact factor: 3.303

8.  Animal models and vaccines for SARS-CoV infection.

Authors:  Anjeanette Roberts; Elaine W Lamirande; Leatrice Vogel; Jadon P Jackson; Christopher D Paddock; Jeannette Guarner; Sherif R Zaki; Timothy Sheahan; Ralph Baric; Kanta Subbarao
Journal:  Virus Res       Date:  2007-05-11       Impact factor: 3.303

9.  Differential role for low pH and cathepsin-mediated cleavage of the viral spike protein during entry of serotype II feline coronaviruses.

Authors:  Andrew D Regan; Renata Shraybman; Rebecca D Cohen; Gary R Whittaker
Journal:  Vet Microbiol       Date:  2008-05-29       Impact factor: 3.293

Review 10.  Dengue hemorrhagic fever in infants: research opportunities ignored.

Authors:  Scott B Halstead; Nguyen Trong Lan; Thein Thein Myint; Than Nu Shwe; Ananda Nisalak; Siripen Kalyanarooj; Suchitra Nimmannitya; Soegeng Soegijanto; David W Vaughn; Timothy P Endy
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.